Global /South Korea /Healthcare /Drug Manufacturers - General /067080
chevron_leftBack
DAE HWA Pharmaceutical Co., Ltd. logo

DAE HWA Pharmaceutical Co., Ltd.

067080
KRX: 067080 Delayed
14,960KRW -0.3%
9.76 USD
As of 6 June 2026, DAE HWA Pharmaceutical Co., Ltd. has a market cap of $170.96M USD, ranking #22039 globally and #907 in South Korea. It ranks #1988 in the Healthcare sector, and #716 in the Drug Manufacturers - General industry.
Global Rank
22039
Country Rank
907
Sector Rank
1988
Industry Rank
716
Key Stats
Market Cap
$170.96MUSD
262.05B KRW
Enterprise Value
$233.42MUSD
357.79B KRW
Revenue (TTM)
$93.33MUSD
143.06B KRW
EBITDA (TTM)
$6.15MUSD
9.43B KRW
Net Income (TTM)
$1.08MUSD
1.65B KRW
EBITDA Margin
6.6%
Profit Margin
1.2%
PE Ratio
159.1
PS Ratio
1.8
PB Ratio
3.3
EV/EBITDA
37.9
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Kim Eun-Seok open_in_new
Employees
308
Founded
1984
Website
dhpharm.co.kr open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-0.3% -0.8% 4.1% -9% -11% -4.3%

News

Loading...

Markets

Exchange Ticker Price
Korea Exchange
MIC: XKRX
PRIMARY
067080
대화제약(주)
ISIN: KR7067080002
Shares Out.:
18.422M1 Shares Float: 12.027M2
TV:
SA:
YF:
GF:
BA:
MS:
14,960 KRW
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About DAE HWA Pharmaceutical Co., Ltd.

DAE HWA Pharmaceutical Co., Ltd., a pharmaceutical company, produces and supplies pharmaceutical products in South Korea. The company offers drugs for anticancer, antibiotics, antifungal and skin ailment, antivirus, anti-allergosis, hemorrhoids, antidepressant, antiepileptic, psychotropic agent, anti respiratory, anti-inflammatory, analgesic, skeletal muscle relaxants, osteoporosis, anti-arthritis, gastro-intestinal, obesity, antispasmodic, diabetics, hypertension, hyperlipemia, antithrombotic and anticoagulant, hepatic, erectile dysfunction, urinary incontinence, prostatic hyperplasia, pregnancy, bug bite, anthelmintics, and cosmetic care, as well as vitamins and minerals, tonics, nutrition products. It also provides transdermal drug delivery system, a pharmaceutical preparation that is applied to the intact skin for systemic absorption; and active pharmaceutical ingredients. The company also exports its products to approximately 22 countries, including Asia, South America, the Middle East, and Africa. DAE HWA Pharmaceutical Co., Ltd. was founded in 1984 and is headquartered in Seoul, South Korea.

Similar Companies

Industry: Drug Manufacturers - General (South Korea)
Name
Market Cap diff.
PE
$9.07B
13.91T KRW
5K%
-
$6.72B
10.3T KRW
4K%
1958.1
$5.2B
7.97T KRW
3K%
29.9
298380
$4.92B
7.55T KRW
3K%
-
000100
$4.51B
6.92T KRW
3K%
35.9
$4.41B
6.76T KRW
2K%
-
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
445K%
38.1
JNJ
$547.28B
320K%
26.4
ABBV
$360.63B
211K%
97.4
$324.68B
256.25B CHF
190K%
19.9
AZN
$289.43B
215.59B GBP
169K%
27.6
NOVN
$277.35B
218.9B CHF
162K%
20.5
chevron_leftBack